Correlation Between Chevron Corp and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chevron Corp and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chevron Corp and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chevron Corp and Bionoid Pharma, you can compare the effects of market volatilities on Chevron Corp and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chevron Corp with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chevron Corp and Bionoid Pharma.

Diversification Opportunities for Chevron Corp and Bionoid Pharma

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Chevron and Bionoid is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Chevron Corp and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Chevron Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chevron Corp are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Chevron Corp i.e., Chevron Corp and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Chevron Corp and Bionoid Pharma

Considering the 90-day investment horizon Chevron Corp is expected to generate 117.18 times less return on investment than Bionoid Pharma. But when comparing it to its historical volatility, Chevron Corp is 42.36 times less risky than Bionoid Pharma. It trades about 0.02 of its potential returns per unit of risk. Bionoid Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  4.00  in Bionoid Pharma on August 29, 2024 and sell it today you would earn a total of  7.00  from holding Bionoid Pharma or generate 175.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Chevron Corp  vs.  Bionoid Pharma

 Performance 
       Timeline  
Chevron Corp 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chevron Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Chevron Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bionoid Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Chevron Corp and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chevron Corp and Bionoid Pharma

The main advantage of trading using opposite Chevron Corp and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chevron Corp position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Chevron Corp and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets